Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake

Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity

(2014) Carlos E. Leite et al.   Pharmacological Reports

Cannabinoid Type-1 Receptor Gene Polymorphisms Are Associated with Central Obesity in a Southern Brazilian Population

(2013) Janaína P. Jaeger et al.   DISEASE MARKERS

Diet and myocardial infarction: A nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy

(2011) P. Pierucci et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Weight loss induced by rimonabant is associated with an altered leptin expression and hypothalamic leptin signaling in diet-induced obese mice

(2010) Paolo Lazzari et al.   BEHAVIOURAL BRAIN RESEARCH

Role of cannabinoid CB1 receptors on macronutrient selection and satiety in rats

(2009) Rodrigo Erick Escartín-Pérez et al.   PHYSIOLOGY & BEHAVIOR

Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations

(2008) Michael Benzinou et al.   HUMAN MOLECULAR GENETICS

Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets

(2008) Isabel Matias et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Genetic variation may influence obesity only under conditions of diet: Analysis of three candidate genes

(2008) Jens Aberle et al.   MOLECULAR GENETICS AND METABOLISM